Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Machine learning can tease out which location-specific—or “area-level”—social determinants of health warrant close monitoring in people who have diabetes and are at risk of losing control over it.
Machine learning is being quickly adapted across the healthcare space to develop precision medicine, and it can also be leveraged to improve the development of new drug treatments and devices by improving the randomized clinical trial process, according to MIT researchers.
Koios Medical, Inc has received 510(k) clearance from the U.S. Food and Drug Administration for Koios DS (Decision Support) Breast 2.0, a new version of its machine learning based platform that assists physicians in the classification and diagnosis of breast cancer.
More hospitals and healthcare providers are seeking medical specialists compared to primary care physicians––and many of these roles comes with the highest starting salaries in the industry.
Several plant-based foods readily available in supermarkets contain bioactive molecules that could not only prevent cancer but also treat it, accomplishing the latter with protective mechanisms similar to those activated by existing clinical therapies.
Researchers from Kaiser Permanente have developed a machine learning algorithm that could help prevent the spread of the HIV virus by finding at-risk patients and getting them on prevention medications. The researchers published the findings of their prediction model in The Lancet HIV.
